What are the contraindications to aprecitentan (Tryvio)?
Aprocitentan-Tryvio has demonstrated promising antihypertensive potential in the treatment of hypertension, but like all prescription drugs, its use has clear contraindications. First, the drug is contraindicated in patients who are allergic to aprecitentan or any ingredient in the drug to avoid severe allergic reactions such as rash, difficulty breathing, or even anaphylactic shock. Secondly, the use of aprecitentan is not recommended for pregnant and breastfeeding women. Since the endothelin pathway is closely related to fetal development and newborn health, the drug may have adverse effects on the fetus, so its use should be avoided during pregnancy. Once the patient is ready to become pregnant, the drug should be stopped in advance and replaced with other antihypertensive regimens under the guidance of a doctor.
In addition, patients with severe hepatic impairment are not suitable for use of aprecitentan. This is because the drug is mainly metabolized in the liver. If the liver is insufficient, it will cause the drug to accumulate in the body and increase the risk of side effects, such as hypotension or edema. Similarly, patients with severe renal insufficiency need to be particularly cautious when using it, because abnormal drug metabolism may aggravate adverse reactions.
It should be noted that aprecitentan interacts with certain drugs, such as strongCYP3A inhibitors may affect their metabolic levels, thereby increasing side effects. Therefore, patients who are taking other antihypertensive drugs, immunosuppressants, or antiviral drugs should carefully decide whether to take concomitant drugs after evaluation by their doctor.
Generally speaking, the contraindications of aprecitentan mainly include allergies, pregnancy and lactation, severe liver and kidney damage, and the risk of some drug interactions. Patients must undergo a comprehensive medical history assessment and laboratory examination before starting treatment. Only after the contraindications are eliminated can the drug exert its best efficacy and ensure safety.
Reference materials:https://go.drugbank.com/drugs/DB15059
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)